Searched for
AMAR LULLA
Blackstone sets its sights on buying out Hamieds from CiplaNon-binding bid likely next week for 33.4% stake, will trigger open offer for 26% more. At current mkt value deal size could be over $6 bn ...- Don't look now, Cipla just might be changing, says Cipla chairman & MD Dr Yusuf HamiedET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.
- Stocks to watch: Cipla, Power Trading Corporation, Bajaj Auto, Bharti Airtel, Zenith Computers, HCL Infosystems, Shiv Vani OilsKaamil Hamied, promoter and chairman YK Hamied’s nephew, is likely to eventually take over the top slot from the incumbent, company veteran...
- Piramal buys Cipla's i-pill for Rs 95 crorePiramal Healthcare bought Cipla’s oral contraceptive brand, i-pill, for Rs 95 crore, to achieve its target of trebling its over-the-counter...
- Union Budget 2010: Drugmakers to benefit from budgetary measuresIndian drugmakers and research establishments will benefit from the increase in weighted deduction on in-house research and development (R&...
- Cipla in talks with global cos for research agreementMumbai-based drugmaker Cipla is in talks with global pharma majors for a drug research and supply agreement, said a top company executive o...
- Indian companies may pitch in with generic version of Tamiflu“We have already received proposals from people on behalf of countries in Latin America, Mexico and Israel. We have the capability to suppl...
- Cipla gets patent for Nexium, Fosamax modified versionsDomestic pharma major Cipla has received product patents for new forms of two blockbuster drugs-Osemaprazole and Alendronate-from the India...
- Rahejas challenge Goa govt’s order to scrap SEZReal estate major K Raheja has challenged the Goa government’s decision to scrap the approved SEZ before the Bombay High Court.
- Cipla’s Goa SEZ runs into trouble, againCipla’s plan to develop an SEZ in Goa received a serious jolt on Friday when the north Goa collector ordered removal of all machinery from ...
- Cipla notice to US NGO on AIDS drugDomestic major Cipla has sent a legal notice to the AIDS Healthcare Foundation, the US-based NGO which has alleged that the Indian company ...
- MRTPC lens on Cipla’s AIDS drugs for AfricaThe Monopolies and Restrictive Trade Practices Commission (MRTPC) has asked its investigation wing to probe a US-based NGO’s allegation tha...
- Cipla net down 30% at Rs 120 crDomestic pharma major Cipla posted results below market expectations for the first quarter ended June.
- Reliance, Cipla in talks for retail pactIf the deal is sealed, Cipla will supply generic pharmaceutical products to Reliance Retail.
- Cipla to pay for overcharging drugsThe govt has told Cipla to pay Rs 193.65 crore, inclusive of interest, for overcharging of five drugs.
- Indian bidders may find Merck bitter pillEven as domestic drug majors, Ranbaxy and Cipla, submitted their bids on Monday for acquiring German drug giant Merck's generics business.
- PEs to bankroll Cipla's Merck bidIndian drug major Cipla and private equity (PE) funds are working out an innovative financing model to bid for Merck’s generic business.
- Cipla may join PE cos in bid for Merck unitDrug major Cipla is exploring the option of joining a consortium of private equity firms in bidding for the generics business of German dru...
- Paswan slashes prices of 886 drugsThe list includes anti-diabetic pills, antibiotics, cough syrups, pain killers and anti-hypertensives.
- AIDS drug Viread prices may dip soonBlockbuster AIDS drug Viread is set to witness a price war in the domestic market in the next few days, benefitting lakhs of patients using...
Load More- Piramal buys Cipla's i-pill for Rs 95 crore
